Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 18, Issue 2, 2003, Pages 1-5

  Munkholm, Pia ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; MESALAZINE; SALAZOSULFAPYRIDINE;

ADENOCARCINOMA; CANCER PREVENTION; CANCER RISK; COLORECTAL CARCINOMA; CONFERENCE PAPER; CROHN DISEASE; DRUG EFFECT; HUMAN; INCIDENCE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMALL INTESTINE CARCINOMA; ULCERATIVE COLITIS;

EID: 0141651527     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.18.s2.2.x     Document Type: Conference Paper

References (25)

1. Ekbom A, Helmick C, Zack M, et al. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-9.
2. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-51.
3. Choi PM, Zelig MP. Similarity of colorectal cancer in CD and UC. Implications for carcinogenesis and prevention. Gut 1994; 35: 950-4.
4. Gyde S, Prior P, Dew MJ, Saunders V, Waterhouse JA, Allan RN. Mortality in ulcerative colitis. Gastroenterology 1982; 83: 36-43.
5. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 1985; 72(Suppl.): S84-6.
6. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988; 29: 206-17.
7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
8. Langholz E. Ulcerative colitis. An epidemiological observational study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999; 46: 400-15.
9. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiologic cohort study. Dan Med Bull 1997; 44: 287-302.
10. Bernstein C, Eaden J, Steinhart H, Munkholm P. Cancer chemoprevention in IBD. Inflamm Bowel Dis 2002; 8: 356-61.
11. Persson PG, Karlen P, Bernell O, et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994; 107: 1675-9.
12. Fireman Z, Grossman A, Lilos P, et al. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scand J Gastroenterol 1989; 24: 346-50.
13. Jess T, Winther K, Munkholm P, Langholz E, Binder V. Is there an increased risk of intestinal and extra intestinal cancer in patients with Crohn's disease? A population based cohort followed from 1962 to 1997. Gastroenterology 2000; 118(Suppl. 2): 1472.
14. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-23.
15. Gillen CD, Walmsley RS, Prior R, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Crohn's disease and colorectal cancer. Gut 1994; 35: 651-5.
16. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 1989; 209: 764-73.
17. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterol 2002; 122: 1808-14.
18. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. N Eng J Med 1990; 323: 1228-33.
19. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-23.
20. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-5.
21. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92: 1285-8.
22. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 1643-9.
23. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998; 115: 1079-83.
24. Askling J, Dickman PW, Broström O, Lapidus A, Löfberg R, Ekbom A. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet, 2001; 357: 262-6.
25. Binder V. Cancer in inflammatory bowel disease. In: Rampton D, ed. Clinical Diagnosis and Management. London: Martin Dunitz, 2000.